Clinical Trials on Post- COVID-19 Syndrome in Russian Federation

Total 164 results

Biosurf LLC.

Active, not recruiting

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

ARDS Due to COVID-19

Russian Federation
Gamaleya Research Institute of Epidemiology and...
Acellena Contract Drug Research and Development

Completed

An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19

Preventive Immunization COVID-19

Russian Federation
National Research Center for Preventive Medicine
National Medical and Surgical Center named after N.I. Pirogov of the Ministry...

Active, not recruiting

Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia (TARGET-VIP)

COVID 19

Russian Federation
Gamaleya Research Institute of Epidemiology and...
Acellena Contract Drug Research and Development

Completed

An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19

Preventive Immunization COVID-19

Russian Federation
Volgograd State Medical University

Active, not recruiting

Thrombohemorrhagic Complications of COVID-19

COVID-19 (Coronavirus Disease 2019)

Russian Federation
Tomsk National Research Medical Center of the Russian...

Recruiting

PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics (PIM-BARS)

Potentially Inappropriate Medications

Russian Federation
Concern GRANIT
Samara State Medical University

Completed

Clinical Trial of a Medical Device "Device for Non-invasive Electromagnetic Therapy "TOR" in the Treatment of COVID-19"

Coronavirus Infection COVID-19

Russian Federation
Materia Medica Holding

Completed

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Post-acute COVID-19 Syndrome

Russian Federation
SPP Pharmaclon Ltd.

Completed

Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19

COVID-19 Respiratory Infection

Russian Federation
SPP Pharmaclon Ltd.

Completed

Study of the Use of the Drug Ingaron in Patients With COVID-19

COVID-19 Respiratory Infection | Viral Pneumonia

Russian Federation
Gamaleya Research Institute of Epidemiology and...
Russian Direct Investment Fund

Active, not recruiting

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

COVID-19 Prevention

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Active, not recruiting

Severity of COVID-19 and Vitamin D Supplementation

COVID-19 Respiratory Infection

Russian Federation
Federal State Budgetary Institution, V. A. Almazov...

Completed

COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation

COVID-19 Respiratory Infection

Russian Federation
Lomonosov Moscow State University Medical Research...

Completed

COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19 (COLORIT)

COVID 19

Russian Federation
Lomonosov Moscow State University Medical Research...

Unknown

BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization (BISCUIT)

COVID 19

Russian Federation
AstraZeneca

Completed

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19 (NOVELLA)

COVID-19, SARS-CoV-2

Russian Federation
Ivan S Moiseev
European University at St. Petersburg; Medical Institute named after Berezin...

Terminated

Real-world Evidence of COVID-19 Vaccines Effectiveness

COVID-19 Pneumonia

Russian Federation
Federal State Budgetary Scientific Institution...

Completed

Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients

Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients

Russian Federation
Valenta Pharm JSC

Not yet recruiting

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

Viral Infection COVID-19

Russian Federation
Valenta Pharm JSC

Completed

Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy Volunteers

COVID-19 | Viral Infection

Russian Federation
NPO Petrovax

Completed

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Fibrosis | Lung Diseases, Interstitial | Lung; Disease, Interstitial, With Fibrosis | Post-Acute COVID-19 Syndrome | Lung Disease With Polymyositis

Russian Federation
SPP Pharmaclon Ltd.

Completed

Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19

COVID-19 Respiratory Infection | Acute Respiratory Disease

Russian Federation
Federal Research Institute of Pediatric Hematology...

Completed

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Lymphoma | Myelodysplastic Syndromes | Leukemia | Opportunistic Infections | GvHD | Graft-versus-Host Disease

Russian Federation
Servier Russia

Recruiting

Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR) (TELESPHOR)

Depression | COVID-19

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Covid19 | SARS-CoV Infection

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome (COVID-NIV)

Covid19 | ARDS

Russian Federation
Gamaleya Research Institute of Epidemiology and...
Government of the city of Moscow; Russian Direct Investment Fund; CRO: iPharma

Unknown

Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (SPUTNIK-LIGHT)

COVID-19 Prevention

Russian Federation
Voronezh Regional Clinical Consultative and Diagnostic...
Charles University, Czech Republic; Voronezh State Medical University named...

Completed

Myocardial Injury and Quality of Life After COVID-19

COVID-19 | Myocardial Injury | Myocarditis Post Infection

Russian Federation
St. Petersburg Research Institute of Vaccines and...

Active, not recruiting

Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

Coronavirus Infections | Respiratory Tract Infections | COVID-19 | COVID-19 Respiratory Infection

Russian Federation
National Research Center - Institute of Immunology...
St. Petersburg Research Institute of Vaccines and Sera

Completed

The siCoV/KK46 Drug Open-safety Study

COVID-19

Russian Federation
Efferon JSC

Completed

Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19

COVID-19

Russian Federation
Pharma VAM

Unknown

Clinical Study in the Treatment of Patients With COVID-19

COVID-19

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia (TOFA-COV-2)

COVID-19

Russian Federation
National Research Center - Institute of Immunology...

Completed

Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19

COVID-19

Russian Federation
National Research Center - Institute of Immunology...
St. Petersburg Research Institute of Vaccines and Sera

Completed

Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19

COVID-19

Russian Federation
Aviron LLC

Unknown

An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19

COVID-19

Russian Federation
Federal Research Clinical Center of Federal Medical...

Unknown

Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients

COVID-19

Russian Federation
National Medical Research Radiological Centre of...

Completed

Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19

Pneumonia, Viral | Covid19

Russian Federation
Supergene, LLC
Russian Academy of Medical Sciences

Terminated

Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial (FORRIF)

COVID-19

Russian Federation
Federal Research Clinical Center of Federal Medical...

Completed

Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease

COVID-19

Russian Federation
Federal Research and Clinical Center of Physical-Chemical...
Federal Research Clinical Center of Federal Medical & Biological Agency,... and other collaborators

Unknown

Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2 (COV2020)

Covid19

Russian Federation
Pirogov Russian National Research Medical University

Not yet recruiting

Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia

Covid19

Russian Federation
Federal Research Clinical Center of Federal Medical...

Completed

Clinical Features of Severe Patients With COVID-19

SARS-CoV2

Russian Federation
Gamaleya Research Institute of Epidemiology and...
Government of the city of Moscow; CRO: Crocus Medical BV

Unknown

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (RESIST)

Covid19 Prevention

Russian Federation
NP Therapeutics

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers

Covid19 | Healthy Volunteers

Russian Federation
Pirogov Russian National Research Medical University
Pfizer

Unknown

Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19 (OPTIMIST)

Covid19

Russian Federation
Gamaleya Research Institute of Epidemiology and...

Unknown

The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older

Coronavirus Infection

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study

Respiratory Failure | Pneumonia, Bacterial | COVID-19 Pneumonia

Russian Federation
Pirogov Russian National Research Medical University
City Clinical Hospital No.52 of Moscow Healthcare Department

Completed

COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU

COVID-19 | Mild to Moderate

Russian Federation
Tomsk National Research Medical Center of the Russian...

Completed

One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia

Covid19 | Cardiac Complication

Russian Federation

Clinical Trials on Post- COVID-19 Syndrome in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations